Backman v. Takeda Pharmaceutical Company Limited
||Takeda Global Research & Development Center, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals North America, Inc., Takeda Pharmaceuticals America, Inc. and Eli Lilly and Company
||October 4, 2011
||North Carolina Eastern District Court
||Southern Division Office
||Louise Wood Flanagan
|Nature of Suit:
||Personal Injury- Product Liability
|Cause of Action:
|Jury Demanded By:
Available Case Documents
The following documents for this case are available for you to view or download:
|Date Filed||#||Document Text|
|December 27, 2011
ORDER granting 18 Motion to Stay - All discovery, including this Court's December 19, 2011 Initial Order Regarding Planning and Scheduling, is hereby stayed in the United States District Court for the Eastern District of North Carolina, so that discovery may proceed in this action in the Actos MDL, subject to further proceedings not inconsistent with the Actos MDL upon any remand from the MDL. Signed by District Judge Louise Wood Flanagan on 12/27/2011. (Baker, C.)
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system.
A subscription to PACER is required.
Access this case on the North Carolina Eastern District Court's Electronic Court Filings (ECF) System
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.